Histopathology | All patients Number (%)b | Persistent DTC after treatment Number (%)c | Negative for DTC after treatment Number (%)c | P valued | |||
---|---|---|---|---|---|---|---|
Number: | n=72 | n=15 | n=57 | ||||
pT-status: | |||||||
pT1a +b | 2 | (2.8) | 0 | (0) | 2 | (100) | |
pT1c | 29 | (40.3) | 6 | (20.7) | 23 | (79.3) | 0.80 |
≥pT2 | 41 | (56.9) | 9 | (22.0) | 32 | (78.0) | |
Histology: | |||||||
IDC | 54 | (76.1) | 8 | (14.8) | 46 | (85.2) | |
ILC | 14 | (19.7) | 7 | (50.0) | 7 | (50.0) | 0.009e |
Others | 3 | (4.2) | 0 | (0) | 3 | (100) | |
Missing | 1 | 0 | 1 | ||||
ER-status: | |||||||
Posf | 54 | (75.0) | 13 | (24.1) | 41 | (75.9) | 0.33 |
Neg | 18 | (25.0) | 2 | (11.1) | 16 | (88.9) | |
PR-status: | |||||||
Posf | 46 | (63.9) | 8 | (17.4) | 38 | (82.6) | 0.38 |
Neg | 26 | (36.1) | 7 | (26.9) | 19 | (73.1) | |
BM1: | |||||||
Pos | 13 | (18.1) | 5 | (38.5) | 8 | (61.5) | 0.11 |
Neg | 59 | (81.9) | 8 | (14.5) | 47 | (85.5) | |
pN-status: | |||||||
pN0 | 28 | (39.4) | 4 | (14.3) | 24 | (85.7) | 0.37 |
pN+ | 43 | (60.6) | 11 | (25.6) | 32 | (74.4) | |
Missing | 1 | 0 | 1 | ||||
Histological grade: | |||||||
Grade1-2 | 51 | (71.8) | 12 | (23.5) | 39 | (76.5) | 0.53 |
Grade3 | 20 | (28.2) | 3 | (15.0) | 17 | (85.0) | |
Missing | 1 | 0 | 1 | ||||
HER2-statusg: | |||||||
Pos | 6 | (15.8) | 0 | (0) | 6 | (100) | 0.57 |
Neg | 32 | (84.2) | 7 | (21.9) | 25 | (78.1) | |
Missing | 1 | 1 |